Chair

Lauren Lemke, PharmD, BCPS

Clinical Pharmacist Specialist

Brown University Health, Providence, RI, USA

Dr. Lauren Lemke oversees the implementation of pharmacogenomics at Brown University Health and is an adjunct clinical assistant professor at the University of Rhode Island College of Pharmacy . She completed a PGY2 clinical pharmacogenomics residency at the University of Florida and has earned certificates in implementation science, teaching, and leadership . Dr. Lemke is passionate about ensuring equitable access to PGx and empowering patients, providers, and health systems to use PGx responsibly.

LLemke@brownhealth.org

Chair-Elect

Jenny Nguyen, PharmD, APh, BCPS

Clinical Pharmacogenomics Specialist

Children’s Hospital Los Angeles, Los Angeles, CA, USA

I am a clinical pharmacogenomics specialist at Children’s Hospital Los Angeles . As part of my role, I help expand pharmacogenomic testing across the health sys tem and integration of these results into electronic health records . My research activities are focused on clinical implementation.

jennguyen@chla.usc.edu

Secretary

Courtney Paetznick, PharmD

Clinical Pharmacogenomics Specialist

Children’s Minnesota, Minneapolis, MN, USA

Courtney Paetznick, PharmD, is a clinical pharmacogenomics specialist at Children’s Minnesota . She earned her Doctor of Pharmacy degree from the University of Minnesota College of Pharmacy and completed both a PGY-1 Pharmacy Practice Residency and a PGY-2 Clinical Pharmacogenomics Residency at Children's Minnesota . Her professional interests focus on pharmacogenomics in pediatric psychiatry, pain man agement, and promoting health equity through pharmacogenomic initiatives.

International Coordinator

Maud Maillard (ORCID Profile)

Clinical Pharmacogenomics Specialist

Oncopole-Claudius Regaud, Pharmacology Lab, Toulouse, France

I am a clinical pharmacist and pharmacogenomics specialist at Oncopole-Claudius Regaud in Toulouse, France . We offer pharmacogenomics-guided dosi ng using an in-house PGx sequencing panel and routinely perform therapeutic drug monitoring for cytotoxics and small-molecule inhibitors . Our research activities are closely integrated with our cl inical practice, and we mainly contribute to studies that aimed at evaluating how patient characteristics influence response to anticancer therapies.

maillard.maud@iuct-oncopole.fr

Membership Coordinator

Halle Brady, PharmD

Clinical Pharmacogenomics Pharmacist

Sanford Health / Sanford Imagenetics, Sioux Falls, SD, USA

Dr. Brady completed her PGY-2 residency in Clinical Pharmacogenomics in Sioux Falls, SD with Sanford Health and upon completion accepted a position with the PGx team . Halle educates patients on pharmacogenomics (PGx) results and com municates and interprets results to both patients and providers . Halle is committed t o clinical pharmacogenomics implementation and advocating for patient safety.

Member at Large

Amanda Elchynski, PharmD, BCPS

Pharmacy Clinical Coordinator, Pharmacogenomics (PGx)

Arkansas Children's Hospital, Little Rock, AR, USA

Dr. Amanda Elchynski is the Clinical Pharmacogenomics Coordinator at Arkansas Children’s Hospital, where she develops and maintains clinical decision support to ols, provides pharmacogen omic result interpretation in collaboration with the clinical laboratory, and leads system-wide clinical implementation efforts . She teaches and precepts pharmacy students and residents in pharmacogenomics.

Member at Large

Danielle Miller, PharmD, BCPPS

Cook Children’s Medical Center, Fort Worth, TX, USA

Danielle graduated from the University of Florida College of Pharmacy and completed both her PGY1 and PGY2 Pediatric Hematology/Oncology Residency at Cook Children’s Medical Center. She then served as the Pediatric Hematology/Oncology Pharmacy Specialist at AdventHealth for Children. In 2025, she returned to Cook Children’s where she now serves as the Pharmacogenomics Pharmacy Specialist, implementing precision medicine strategies to personalize therapy and optimize medication use in pediatric patients.

Member at Large

Benjamin Duong, PharmD

Clinical Pharmacogenomics Service Manager

Nemours Children’s Health, Delaware Valley, DE, USA

Dr. Benjamin Duong earned his PharmD from the University of Florida in Gainesville, Florida, completed a PGY1 Hospital Pharmacy with Memorial Hospital Miramar in Miramar, Florida, and his PGY2 Clinical Pharmacogenomics residency at the University of Florida. He currently leads the implementation of pharmacogenomics across Nemours Children's Health, a multistate institution with hospitals and clinics in Delaware, New Jersey, Pennsylvania, and Florida. Dr. Duong implemented the Nemours Clinical Pharmacogenomics Service which includes developing an in-house pharmacogenomic panel with the Molecular Diagnostic Laboratory, integrating pharmacogenetic clinical decision support into the electronic medical records, providing clinical recommendations, and educating patients and health care professionals regarding pharmacogenomics. He has published over two dozen papers in pharmacogenomics, with a focus on implementation practices.